NOVONIX (NVX) legal chief reports large performance rights holdings

Rhea-AI Filing Summary

NOVONIX Ltd reported the initial equity holdings of Chief Legal and Risk Officer Kimberly J. Heimert. The filing lists two blocks of performance rights that can convert to ordinary shares at an exercise price of $0.0000 per share.

One block relates to 489,818 underlying ordinary shares with an exercise date on December 31, 2027 and expiration on December 31, 2028. The second block relates to 1,724,285 underlying ordinary shares with an exercise date on December 31, 2028 and expiration on December 31, 2029. The filing does not show any buy or sell transactions, only these derivative holdings.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Heimert Kimberly J.

(Last) (First) (Middle)

1029 WEST 19TH STREET

(Street)

CHATTANOOGA TN 37408

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
NOVONIX Ltd [ NVX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal and Risk Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance rights	12/31/2027	12/31/2028	Ordinary shares	489,818	$0	D
Performance rights	12/31/2028	12/31/2029	Ordinary shares	1,724,285	$0	D

Explanation of Responses:

Remarks:

Performance Rights vest based on 3 year TSR performance subject to a revenue modifier.

	Suzanne Yeates	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does NOVONIX (NVX) disclose in Kimberly Heimert’s Form 3?

NOVONIX’s Form 3 shows Chief Legal and Risk Officer Kimberly Heimert holding performance rights over ordinary shares. It reports her derivative positions, including underlying share amounts, exercise price of $0.0000, and future exercise and expiration dates, without recording any purchase or sale transactions.

How many NOVONIX (NVX) shares are covered by Kimberly Heimert’s performance rights?

Kimberly Heimert’s performance rights relate to 489,818 and 1,724,285 underlying NOVONIX ordinary shares. These blocks represent derivative interests that may convert into shares if conditions are met, giving detailed visibility into her potential equity exposure as an executive.

Are there any buy or sell transactions reported for NOVONIX (NVX) in this Form 3?

No buy or sell transactions are reported. The Form 3 is an initial statement of beneficial ownership that lists Kimberly Heimert’s performance rights positions only, with no open-market purchases, sales, or option exercises disclosed in this particular filing.

What are the key dates for Kimberly Heimert’s NOVONIX (NVX) performance rights?

One performance rights block has an exercise date of December 31, 2027 and expiration on December 31, 2028. The second block has an exercise date of December 31, 2028 and expiration on December 31, 2029, defining when each award can be used.

What is the exercise price of NOVONIX (NVX) performance rights held by Kimberly Heimert?

Both sets of performance rights for Kimberly Heimert have an exercise price of $0.0000 per share. This means, subject to vesting or performance conditions, the underlying ordinary shares can be acquired without additional cash payment upon exercise.